TriSalus Life Sciences (TLSIW) Long-Term Debt Issuances (2022 - 2025)

TriSalus Life Sciences (TLSIW) has 4 years of Long-Term Debt Issuances data on file, last reported at $10.0 million in Q1 2025.

• For the quarter ending Q1 2025, Long-Term Debt Issuances changed N/A year-over-year to $10.0 million; the trailing twelve-month figure through Dec 2025 stood at $10.0 million (down 60.0% YoY), and the FY2025 full-year result was $10.0 million, down 60.0% from the prior year.
• Long-Term Debt Issuances for Q1 2025 stood at $10.0 million, down from $25.0 million in the prior quarter.
• Across five years, Long-Term Debt Issuances topped out at $25.0 million in Q2 2024 and bottomed at -$415222.0 in Q2 2023.
• The 4-year median for Long-Term Debt Issuances is $340111.0 (2022), against an average of $5.9 million.
• The widest annual swing landed in 2023, when Long-Term Debt Issuances tumbled 407.57%; it then jumped 6120.88% in 2024.
• A 4-year view of Long-Term Debt Issuances shows it stood at $135000.0 in 2022, then sank by 407.57% to -$415222.0 in 2023, then surged by 6120.88% to $25.0 million in 2024, then sank by 60.0% to $10.0 million in 2025.
• The last three Long-Term Debt Issuances figures came in at $10.0 million (Q1 2025), $25.0 million (Q2 2024), and -$415222.0 (Q2 2023), per Business Quant data.

Peer Comparison